Navigation Links
The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris
Date:5/20/2013

Paris, France (PRWEB) May 20, 2013

On 25-28 July, 2013, UPCP 2013 will convene once again, this time – in Paris - the beautiful city of lights.

According to Prof. Eddy Karnieli, the congress chairperson, "Personalized Medicine is revolutionizing the medical world. Understanding and integrating genetic and molecular information with traditional clinical knowledge is the hallmark of this transformation. Much of the present medical practice is based on standard care derived from the epidemiologic studies of large cohorts that do not take into account the individual’s genetic, proteomic, and metabolic characteristics.”

This second UPCP 2013 Congress will focus mainly on the essential clinical, imaging, genomic, proteomic, metabolomic, pharmacogenomic and biomarker data necessary to predict, prevent and treat major medical conditions concerning cancer and metabolism (diabetes and obesity).

The UPCP 2013 faculty includes internationally renowned speakers, whose areas of expertise include chemical engineering, genetics, genomic medicine, computer science, radiology, nuclear medicine, obesity, endocrinology, metabolism and more. Many "hot topics" will be covered and discussed, such as implementing personalized oncology treatment, targeted personalized chemotherapy, analysis of genomic data, and more.

This year's opening lecture will be given by Dr. David Sidransky – the renowned oncologist and research scientist named and profiled by TIME magazine in 2001 as one of America’s top 10 physicians and scientists for his work on microsatellite cancer diagnostics.

Visit our Preliminary Program to read more.

This year's congress will take place at the Marriott Rive Gauche, with easy access to the airport as well as the Metro station and all public transportation. The beautiful city of Paris is always a delight! Make the most of this wonderful opportunity to see some of the world's finest museums, visit the famous sights and enjoy the delicious French cuisine.

Register Now and Secure Your Spot or visit the UPCP 2013 Homepage for more information.

http://www.upcp.org

Read the full story at http://www.prweb.com/releases/2013/5/prweb10740649.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Yongye International Provides Update on Status of Proposed Go Private Offer
2. Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia
3. Palm Clinic New Zealand Doctor Trains Chinese Doctors at International Micro-Plastic Annual Exchange Conference
4. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
5. Dyadic International Reports First Quarter 2013 Financial Results
6. Ondine's CEO Carolyn Cross to be a Plenary Session Speaker at 14th World Congress of International Photodynamic Association
7. Data Sciences International (DSI) in Space
8. Yongye International Announces First Quarter 2013 Financial Results
9. Dr. Szczepan Baran will be Presenting at the International Microsurgical Simulation Society at Columbia University in New York
10. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
11. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):